Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
278
278 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- SFA002Phase 31 trial
SFA Therapeutics · Psoriasis (PsO)
- TH07Phase 31 trial
Triple Hair Inc · Androgenic Alopecia
- NM8074Phase 28 trials
NovelMed Therapeutics · Paroxysmal Nocturnal Hemoglobinuria, Dermatomyositis, PNH - Paroxysmal Nocturnal Hemoglobinuria
- rapcabtagene autoleucelYTB323Phase 28 trials
Novartis · Lupus Nephritis, Rheumatoid Arthritis (RA) and Sjögren's Disease (SjD), ANCA Associated Vasculitis (AAV)
- UC-MSCRY_SW01 cell, Human umbilical cord mesenchymal stem cellsPhase 28 trials
Jiangsu Renocell Biotech Company · Acute Respiratory Distress Syndrome, Lupus Nephritis, Spinocerebellar Ataxia Type 1
- AK139Phase 26 trials
Akeso · Asthma, Moderate-to-Severe Atopic Dermatitis, Chronic Spontaneous Urticaria
- brivekimigSAR442970Phase 25 trials
Sanofi · Focal Segmental Glomerulosclerosis, Glomerulonephritis Minimal Lesion, Type 1 Diabetes Mellitus
- SHR-1139Phase 25 trials
Guangdong Hengrui Pharmaceutical Co., Ltd · Moderate to Severe Plaque Psoriasis, Palmoplantar Pustulosis of Adults, Pyoderma Gangrenosum
- SHR-2173Phase 25 trials
Guangdong Hengrui Pharmaceutical Co., Ltd · Generalized Myasthenia Gravis, Active Lupus Nephritis, Primary IgA Nephropathy
- Descartes-08Phase 24 trials
Cartesian Therapeutics · Myasthenia Gravis, Generalized, Childhood-onset Systemic Lupus Erythematous, ANCA-Associated Vasculitis (AAV)
- EVO756Phase 24 trials
Evommune, Inc. · Migraine, Chronic Inducible Urticaria, Atopic Dermatitis
- MAS825ArumakimigPhase 24 trials
Novartis · NLRC4-GOF, AIFEC (Autoinflammation With Infantile Enterocolitis), XIAP Deficiency, CDC42 Mutations, Still´s Disease, VEXAS Syndrome
- MORF-057zotemtegrast, LY4268989Phase 24 trials
Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company) · Inflammatory Bowel Diseases, Crohn's Disease, Ulcerative Colitis (UC)
- SecretomeConditioned, Umbilical Cord Mesenchymal Stem Cells derived ConditionedPhase 24 trials
PT. Prodia Stem Cell Indonesia · Acute Respiratory Distress Syndrome, Androgenetic Alopecia, Ischemic Stroke
- AP1189Phase 23 trials
SynAct Pharma Aps · Rheumatoid Arthritis (RA), Nephrotic Syndrome Due to Idiopathic Membranous Nephropathy, Severe Proteinuria Due to Idiopathic Membranous Nephropathy
- BudoprutugTNT119Phase 23 trials
Climb Bio, Inc. · Primary Membranous Nephropathy, Systemic Lupus Erthematosus, Immune Thrombocytopenia (ITP)
- CBP-0276Phase 23 trials
Clarent Biopharma, Inc. · Psoriasis, Arthritic Psoriasis, Hip or Knee Replacement
- DDY391Phase 23 trials
Novartis · Moderate to Severe Psoriatic Arthritis, Sjögren's Disease
- ENV-294Phase 23 trials
Enveda Therapeutics · Atopic Dermatitis (AD), Atopic Dermatitis, Asthma
- ESG206ESG206-2Phase 23 trials
Shanghai Escugen Biotechnology Co., Ltd · Systemic Lupus Erythematosus (SLE), Immune Thrombocytopenia (ITP), Primary Sjögren Syndrome
- GalvokimigUCB9741Phase 23 trials
UCB · Chronic Obstructive Pulmonary Disease With Chronic Bronchitis, Atopic Dermatitis, Non-cystic Fibrosis Bronchiectasis
- GenSci048Phase 23 trials
Changchun GeneScience Pharmaceutical Co., Ltd. · Uveitis, Systemic Sclerosis Associated Interstitial Lung Disease, Rheumatoid Arthritis Associated Interstitial Lung Disease (RA-ILD)
- GIA632Phase 23 trials
Novartis · Atopic Dermatitis, Non-segmental Vitiligo, Cutaneous Lichen Planus
- HS_SW01 cellsHS_SW01Phase 23 trials
Shenzhen Huishan Biotechnology Co., Ltd. · Ankylosing Spondylitis, Primary Ovarian Insufficiency (Poi), Systemic Sclerosis (SSc)
- HSK39297 200mgQDPhase 23 trials
Haisco Pharmaceutical Group Co., Ltd. · IgA Nephropathy (IgAN), Lupus Nephritis (LN)
- IMG-007Phase 23 trials
Inmagene LLC · Atopic Dermatitis, Atopic Dermatitis Eczema, Eczema
- IPG11406Phase 23 trials
Nanjing Immunophage Biotech Co., Ltd · Lupus Nephritis, Moderately to Severely Active Ulcerative Colitis (UC)
- KT-621Phase 23 trials
Kymera Therapeutics, Inc. · Eosinophilic Asthma, Atopic Dermatitis, Asthma (Diagnosis)
- LT-002-158Phase 23 trials
Leadingtac Pharmaceutical (Shaoxing) Co., Ltd. · Atopic Dermatitis (AD), Hidradenitis Suppurativa (HS)
- ORKA-002Phase 23 trials
Oruka Therapeutics, Inc. · Plaque Psoriasis, Hidradenitis Suppurativa (HS)
- QLS12010Phase 23 trials
Qilu Pharmaceutical Co., Ltd. · Adults With Moderate-to-severe Hidradenitis Suppurativa, Moderate-to-severe Atopic Dermatitis, Rheumatoid Arthritis (RA)
- RSS0393Phase 23 trials
Jiangsu HengRui Medicine Co., Ltd. · Psoriatic Subjects, Plaque Psoriasis in Children, Plaque Psoriasis in Adolescents
- AB-101zabalafinPhase 22 trials
Alphyn Biologics · Atopic Dermatitis (Eczema), Atopic Dermatitis Eczema, Atopic Dermatitis
- ABBV-295Phase 22 trials
AbbVie · Obesity, Overweight, Moderate to Severe Psoriasis
- ABBV-701Phase 22 trials
AbbVie · Crohn's Disease, Ulcerative Colitis, Psoriatic Arthritis
- ADX-914bempikibartPhase 22 trials
Q32 Bio Inc. · Atopic Dermatitis, Alopecia Areata
- AGMB-129OntunisertibPhase 22 trials
Agomab Spain S.L.U. · Fibrostenotic Crohn's Disease
- AK120JAK inhibitor users need to double the initial dosePhase 22 trials
Akeso · Atopic Dermatitis
- anti-TL1A monoclonal antibodyPhase 22 trials
Biocad · Ulcerative Colitis (UC), Crohn's Disease (CD)
- APG777Phase 22 trials
Apogee Therapeutics, Inc. · Atopic Dermatitis
- AZD7798Phase 22 trials
AstraZeneca · Moderate to Severe Crohn's Disease, Crohn's Disease
- BCMA-CD19-IL-15Phase 22 trials
iCell Gene Therapeutics · Inflammatory Bowel Diseases (IBD), Systemic Lupus Erythematosus (SLE), Lupus Nephritis (LN)
- BLU-808Phase 22 trials
Blueprint Medicines Corporation · Chronic Inducible Urticaria, Chronic Spontaneous Urticaria, Allergic Rhinoconjunctivitis
- C-CAR168Phase 22 trials
AbelZeta Inc. · Lupus Nephritis (LN), Systemic Lupus Erythematosus (SLE), Autoimmune Diseases
- CadefrecitinibGLPG3667Phase 22 trials
Lakefront Biotherapeutics NV · Dermatomyositis, Systemic Lupus Erythematosus
- CamoteskimabAPL-9109Phase 22 trials
Apollo Therapeutics Ltd · Atopic Dermatitis, Atopic, Dermatitis
- CGB-500Phase 22 trials
CAGE Bio Inc. · Atopic Dermatitis (AD)
- CIT-013Phase 22 trials
Citryll BV · Hidradenitis Suppurativa (HS), Rheumatoid Arthritis
- CIT-013 dosePhase 22 trials
Citryll BV · Hidradenitis Suppurativa (HS), Rheumatoid Arthritis
- CRC01Phase 22 trials
Curocell Inc. · Relapsed Large B-cell Lymphoma, Refractory Large B-cell Lymphoma, Diffuse Large B-cell Lymphoma (DLBCL)
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.